Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2026 07:30 ET | Source: Marvel Biosciences Corp.

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist
March 24, 2026 16:40 ET | Source: PROLIM Corporation

PROLIM Expands Global Salesforce, Snowflake, and Industrial AI Capabilities by Rebranding Kasmo Digital

PROLIM integrates Kasmo Digital to unify AI, data, and cloud capabilities across Salesforce, Snowflake, and Siemens ecosystems.